Ranbaxy Laboratories Limited
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Ranbaxy Laboratories Limited sits in the top decile of US sponsors by registered trial count (#407 of 15,742 sponsors by registered trial count).
Ranbaxy Laboratories Limited: 44 sponsored US clinical trials, none currently recruiting.
Ranbaxy Laboratories Limited sponsors 44 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 44 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 9 trials.
Top-decile sponsor footprint
Ranbaxy Laboratories Limited ranks in the top decile of sponsors by registered trial count (#407 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
44 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
44 total, page 1 of 1
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions
NCT01499771
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
NCT01499758
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
NCT01276080
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions
NCT01276067
Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions
NCT00778427
Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions
NCT00778466
Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions
NCT00778180
Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions
NCT00778973
Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions
NCT00779051
Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions
NCT00779441
Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions
NCT00779350
Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions
NCT00775905
Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions
NCT00775151
Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions
NCT00775177
Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions
NCT00775918
Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions
NCT00775580
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions
NCT00776022
Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions
NCT00778115
Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions
NCT01222923
Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions
NCT00778674
Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
NCT01222975
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions
NCT00776139
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions
NCT00779233
Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions
NCT00778726
Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions
NCT00778791
Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions
NCT00778141
Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions
NCT00775996
Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions
NCT00778024
Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions
NCT00776620
Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions
NCT00776490
Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions
NCT00777972
Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions
NCT00778713
Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.
NCT00774644
Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
NCT00774696
Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions
NCT00777413
Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions
NCT00776334
Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions
NCT00776542
Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions
NCT00776672
Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions
NCT00778284
Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions
NCT00778050
Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions
NCT00778661
Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions
NCT00778232
Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions
NCT00778401
Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions
NCT00775359
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
Therapeutic Areas
How the Ranbaxy Laboratories Limited early-phase archive is shaped
44 indexed studies, none listed as recruiting (0% open); 44 completed (100%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Healthy (9 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Ranbaxy Laboratories Limited: archived-pipeline peers nationwide
Peers matched on 44 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Ranbaxy Laboratories Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 44 archived trials
- Agios Pharmaceuticals · 44 trials · 7% recruiting
- Beth Israel Medical Center · 44 trials · 0% recruiting
- Innovative Medical · 44 trials · 0% recruiting
- Kowa Research Institute · 44 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Ranbaxy Laboratories Limited page
44 registered trials is a research-attention snapshot, not an endorsement of Ranbaxy Laboratories Limited or any single study.
- None of Ranbaxy Laboratories Limited's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Ranbaxy Laboratories Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ranbaxy Laboratories Limited pipeline card: 44 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.